COPD News

Asthma and childhood wheezy bronchitis appeared associated with increased risk for COPD and reduced ventilatory function, according to results of a 50-year cohort study.

It is premature to recommend the designation of asthma-COPD overlap syndrome as a disease in primary care, according to a review article published in The New England Journal of Medicine.

N-acetylcysteine significantly reduced exacerbation events among individuals with chronic bronchitis and COPD, according to results of a meta-analysis.

The FDA approved Spiriva Respimat for the long-term, once-daily treatment of asthma in patients aged 12 years and older, according to a manufacturer press release.

Spiromax inhalers demonstrated delivery of consistent, accurate doses throughout the inhaler’s life after exposures to common every day elements, according to study results.

Short-term and long-term use of short-acting beta 2-agonist salbutamol 90 μg appeared associated with increased short- and long-term exacerbation of chronic obstructive pulmonary disease, according to study results.

Smokers with COPD reported they received significantly more information about quitting and advice to quit from health care providers than smokers without the disease, according to study results.

Early follow-up visits to pulmonologists after hospital discharge appeared to significantly reduce the readmission rate in patients with COPD, according to results of a retrospective study.

Researchers demonstrated the effective use of clinical asthma features for the diagnosis of asthma-COPD overlap syndrome in a cohort of patients with COPD.

The U.S. Preventive Services Task Force has recommended against primary care screening for COPD in adults not showing symptoms suggestive of the disease, according to a draft recommendation statement.